Antibacterial Effect Assessment of Chitosan Films: a Method Comparison
Burcu Kaya, Nükhet Nilüfer Zorba
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Burcu Kaya, Nükhet Nilüfer Zorba
Burcu Kaya, Nükhet Nilüfer Zorba
Burcu Kaya, Nükhet Nilüfer Zorba
The antibacterial effect has been determined by using different methods in film studies. However, a standard method for determining the antimicrobial activity of chitosan films was not suggested. Therefore, this study determined the antibacterial efficacy of films of different formulations against Staphyloccocus …
Merve Şentürk, Sıla Çatal, İlay Berke, Burcu Kaya et autres
Abstract Background and Aims Kidney transplantation is the best treatment for end-stage renal disease (ESRD). Osteoporosis is a common health problem in kidney transplant recipients. It is known that the risk of bone fracture increases by 30% in the first 3 years …
tr (code pays fourni par la source)
Özgür Akın Oto, Savaş Öztürk, Mustafa Arıcı, Arzu Velioğlu et autres
ABSTRACT Background In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group. Method The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need …
tr (code pays fourni par la source)
Cuma Bülent Gul, Mehmet Küçük, Savaş Öztürk, Erol Demir et autres
tr (code pays fourni par la source)
Burcu Kaya, Dilek Barutçu Ataş, Elif Tükenmez Tigen, Ebru Aşıcıoğlu et autres
OBJECTIVES: Kidney transplant recipients are among the high-risk groups for severe COVID-19. To date, no specific antiviral agent has proved uniformly effective against SARS-CoV-2. Favipiravir, the recommended drug by the Turkish Ministry of Health, was uniformly supplied to all patients diagnosed with …
tr (code pays fourni par la source)
Elif Tükenmez Tigen, EBRU AŞICIOĞLU, Burcu Kaya, DİLEK BARUTÇU ATAŞ et autres
Giriş: Renal transplantasyon hastaları Covid-19 hastalığı açısından yüksek riskli grupta yer almaktadır. Günümüzde henüz SARS-CoV2’ye karşı etkinliği net olarak kanıtlanmış bir anti-viral ajan bulunmamaktadır. Türkiye Cumhuriyeti Sağlık Bakanlığı Covid-19 tedavi rehberi önerisi ile hastaların rutin ilk basamak tedavisinde favipiravir önerilmektedir. Çalışmamızda Covid-19 …
Burcu Kaya, Dilek Barutçu Ataş, Elif Tigen Tükenmez, Ebru Aşıcıoğlu et autres
Aim: Kidney transplant patients are amongst the high-risk groups for severe Covid 19. To date, no specific antiviral agent has been found uniformly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Favipiravir, the recommended drug by The Turkish Ministry of Health, …
tr (code pays fourni par la source)
Arzu Velioğlu, Burcu Kaya, Basar Aykent, Bige Özkan et autres
BACKGROUND: Kidney transplantation (KT) recipients are at increased risk of low bone density (LBD) and fractures. In this retrospective study, we investigated bone mineral density (BMD), vertebral fractures, calculated risk for major osteoporotic fractures (MOF), and hip fractures in the KT recipients. …
tr (code pays fourni par la source)
Burcu Kaya, Halime Mualla Nizam, Arzu Velioğlu, Deniz Filinte et autres
Kaya, Burcu MD; Nizam, Halime Mualla MD; Velioglu, Arzu MD; Filinte, Deniz MD; Kaya, Handan MD; Tuglular, Serhan MDAuthor Information
tr (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic